164 related articles for article (PubMed ID: 28526707)
1.
Zamorano P; Marín N; Córdova F; Aguilar A; Meininger C; Boric MP; Golenhofen N; Contreras JE; Sarmiento J; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H66-H71. PubMed ID: 28526707
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.
Marín N; Zamorano P; Carrasco R; Mujica P; González FG; Quezada C; Meininger CJ; Boric MP; Durán WN; Sánchez FA
Circ Res; 2012 Aug; 111(5):553-63. PubMed ID: 22777005
[TBL] [Abstract][Full Text] [Related]
3. Endothelial mechanisms for inactivation of inflammation-induced hyperpermeability.
Nepali PR; Burboa PC; Lillo MA; Mujica PE; Iwahashi T; Zhang J; Durán RG; Boric M; Golenhofen N; Kim DD; Alves NG; Thomas AP; Breslin JW; Sánchez FA; Durán WN
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H610-H623. PubMed ID: 36867447
[TBL] [Abstract][Full Text] [Related]
4. Vasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance.
Cheng AM; Rizzo-DeLeon N; Wilson CL; Lee WJ; Tateya S; Clowes AW; Schwartz MW; Kim F
Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E571-9. PubMed ID: 25117404
[TBL] [Abstract][Full Text] [Related]
5. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.
Sánchez FA; Kim DD; Durán RG; Meininger CJ; Durán WN
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1642-8. PubMed ID: 18708444
[TBL] [Abstract][Full Text] [Related]
6. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier.
Waschke J; Burger S; Curry FR; Drenckhahn D; Adamson RH
Histochem Cell Biol; 2006 Apr; 125(4):397-406. PubMed ID: 16195887
[TBL] [Abstract][Full Text] [Related]
7. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium.
Schlegel N; Waschke J
J Cell Physiol; 2009 Aug; 220(2):357-66. PubMed ID: 19347869
[TBL] [Abstract][Full Text] [Related]
8. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.
Sánchez FA; Rana R; Kim DD; Iwahashi T; Zheng R; Lal BK; Gordon DM; Meininger CJ; Durán WN
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6849-53. PubMed ID: 19342481
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.
Sánchez FA; Rana R; González FG; Iwahashi T; Durán RG; Fulton DJ; Beuve AV; Kim DD; Durán WN
J Biol Chem; 2011 Sep; 286(35):30409-30414. PubMed ID: 21757745
[TBL] [Abstract][Full Text] [Related]
10. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability.
Thibeault S; Rautureau Y; Oubaha M; Faubert D; Wilkes BC; Delisle C; Gratton JP
Mol Cell; 2010 Aug; 39(3):468-76. PubMed ID: 20705246
[TBL] [Abstract][Full Text] [Related]
11. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells.
Schlegel N; Waschke J
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C453-62. PubMed ID: 19118163
[TBL] [Abstract][Full Text] [Related]
12. The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization.
Schlegel N; Burger S; Golenhofen N; Walter U; Drenckhahn D; Waschke J
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C178-88. PubMed ID: 17989211
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs.
Profirovic J; Han J; Andreeva AV; Neamu RF; Pavlovic S; Vogel SM; Walter U; Voyno-Yasenetskaya TA
J Cell Physiol; 2011 May; 226(5):1255-64. PubMed ID: 20945373
[TBL] [Abstract][Full Text] [Related]
14. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding.
Tateya S; Rizzo NO; Handa P; Cheng AM; Morgan-Stevenson V; Daum G; Clowes AW; Morton GJ; Schwartz MW; Kim F
Diabetes; 2011 Nov; 60(11):2792-801. PubMed ID: 21911751
[TBL] [Abstract][Full Text] [Related]
15. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.
Hatakeyama T; Pappas PJ; Hobson RW; Boric MP; Sessa WC; Durán WN
J Physiol; 2006 Jul; 574(Pt 1):275-81. PubMed ID: 16675496
[TBL] [Abstract][Full Text] [Related]
16. TNF-α-activated eNOS signaling increases leukocyte adhesion through the
Aguilar G; Córdova F; Koning T; Sarmiento J; Boric MP; Birukov K; Cancino J; Varas-Godoy M; Soza A; Alves NG; Mujica PE; Durán WN; Ehrenfeld P; Sánchez FA
Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1083-H1095. PubMed ID: 34652985
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
18. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability.
Comerford KM; Lawrence DW; Synnestvedt K; Levi BP; Colgan SP
FASEB J; 2002 Apr; 16(6):583-5. PubMed ID: 11919161
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury.
Henes J; Schmit MA; Morote-Garcia JC; Mirakaj V; Köhler D; Glover L; Eldh T; Walter U; Karhausen J; Colgan SP; Rosenberger P
FASEB J; 2009 Dec; 23(12):4244-55. PubMed ID: 19690214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
